Compare KNTK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNTK | ZLAB |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | N/A | 2017 |
| Metric | KNTK | ZLAB |
|---|---|---|
| Price | $35.46 | $18.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $48.00 | ★ $57.22 |
| AVG Volume (30 Days) | ★ 1.1M | 841.3K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 8.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $1,719,686,000.00 | $441,629,000.00 |
| Revenue This Year | $26.57 | $26.16 |
| Revenue Next Year | $17.00 | $30.62 |
| P/E Ratio | $85.17 | ★ N/A |
| Revenue Growth | 18.92 | ★ 24.14 |
| 52 Week Low | $31.33 | $16.82 |
| 52 Week High | $67.60 | $44.34 |
| Indicator | KNTK | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 50.18 | 40.35 |
| Support Level | $33.38 | $17.37 |
| Resistance Level | $35.99 | $19.01 |
| Average True Range (ATR) | 1.22 | 0.63 |
| MACD | 0.01 | 0.31 |
| Stochastic Oscillator | 38.25 | 57.51 |
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.